FdaApplication
NDA 206321
Identifiers
- fda_app_no: NDA206321
Properties
| Property | Value |
|---|---|
| applicant_name | NOVO NORDISK INC |
| application_type | NDA |
| approval_date | 2014-12-23 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SAXENDA | LIRAGLUTIDE | 18MG/3ML (6MG/ML) | SOLUTION;SUBCUTANEOUS |
1 product